An open label, randomized, multi-center, phase IIIB, parallel group switching study to compare the efficacy and safety of lipid lowering agents atorvastatin and simvastatin with rosuvastatin in high risk subjects with type IIA and IIB hypercholesterolemia

Trial Profile

An open label, randomized, multi-center, phase IIIB, parallel group switching study to compare the efficacy and safety of lipid lowering agents atorvastatin and simvastatin with rosuvastatin in high risk subjects with type IIA and IIB hypercholesterolemia

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Apr 2008

At a glance

  • Drugs Rosuvastatin (Primary) ; Atorvastatin; Simvastatin
  • Indications Hyperlipoproteinaemia type II; Hypertriglyceridaemia
  • Focus Therapeutic Use
  • Acronyms MERCURY-II
  • Sponsors AstraZeneca
  • Most Recent Events

    • 30 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top